Peptide Synthesis Market: USD 2.59 Billion by 2031, Driven by Therapeutic Demand & Advanced Synthesis Technologies, Says Mordor Intelligence
Source: PRNewswire· August 18, 2026
SynaBot summary
The global market for synthesizing peptides, crucial components in drug development, is expected to grow significantly, reaching $2.59 billion by 2031. This expansion is fueled by increasing demand for peptide-based therapies and improvements in synthesis methods.
Key takeaways
- Peptide synthesis market to hit $2.59 billion by 2031
- Therapeutic demand is a primary growth driver
- Technological advancements are improving synthesis efficiency
- Impacts AI in drug discovery and personalized medicine
Why it matters
Advances in peptide synthesis directly impact the development of new AI-driven therapeutics and diagnostic tools. For AI professionals, this means more sophisticated biological data and models, potentially accelerating breakthroughs in personalized medicine and drug discovery.
This story was reported by PRNewswire. Read the full original article:
Read on PRNewswire Try this on SynaBot
Related AI assistants, prompts, and tools from the SynaBot catalog.
AI Assistants
AI Tools
- Zoom MarketingZoom Marketing offers AI-driven marketing automation tailored for SMBs, simplifying customer engagement and lead nurturing. It helps businesses grow with intelligent campaigns and insights.
- MarketMuseMarketMuse utilizes AI to analyze content performance and suggest improvements for SEO and content strategy. It helps create comprehensive, authoritative content that ranks high in search engines.
- Synthesia (Marketing)Synthesia empowers marketing teams to create personalized video content with AI avatars for various campaigns, including product announcements, lead generation, and customer onboarding. It allows for quick, cost-effective video production without traditional filming, making tailored messaging scalable. Perfect for enhancing brand communication.
